Dear MRI Insider,
Imaging of the placenta can reveal a great deal about both maternal and fetal health, and Greek researchers are convinced that 1-tesla open MRI is an excellent diagnostic tool for this purpose.
A group from Mitera Hospital in Athens conducted 26 placental MRI examinations, and the team's results are worth a close inspection. Interestingly, the researchers also found that during the course of the pregnancy both the placenta appearance and its location change, so imaging evaluation of the location with MRI is ideally delayed and performed during the end of the third trimester. Get the full story here.
In a second article posted today in your MRI Community, we have a report about joint Canadian-Swiss research involving an MRI technique that examines folds in the brain's surface. The group collected MRI data from 161 participants and concluded that MRI can help predict which patients with prepsychotic symptoms will go on to develop full-blown psychosis. To learn more, click here.
Meanwhile, a team from the University of Turin in Italy has created 3D-printed models based on the MRI scans of individuals with intact anterior cruciate ligaments. The researchers found the suggested graft length from the 3D-printed knee was nearly the same as the length determined by examining multiplanar reconstruction MRI scans. Click here for the full details.
Maximizing productivity and throughput is a vital consideration in any MRI unit, so don't miss Dr. Giles Maskell's top 10 practical and timely tips on how to work more effectively. For his practical and timely advice, click here.
The German media has published some hard-hitting articles about the safety of gadolinium-based contrast agents. Many patients are reading these reports, so radiologists and radiographers must know what's being written. Dr. Peter Rinck, PhD, is following this topic, and to get his views, click here.
This letter features only a few of the numerous articles posted over recent weeks in the MRI Community. Please scroll through the full list of our coverage below.
